Adnavance Technologies is an early-stage developer of direct detection molecular diagnostic tests. The companyâ€™s patented and ultra-sensitive metalized-DNA (M-DNAâ„¢) technology may eliminate the need for amplification for a large number of these tests. This technology provides many significant advantages over existing methods, including ease of use, time to result and cost. The platform is simple and inexpensive and is expected to receive FDA approval for use by any laboratory.
Funding Rounds (2) - $7.6MUpdate
BDC Venture Capital is a major venture capital investor in Canada, active at every stage of the...
JovInvestment Management was added to CrunchBase in 2009
Canadian Venture Capital Firm
MDS Capital was added to CrunchBase in 2010
A Financial Institution
11494 Sorrento Valley Road, Suite H
San Diego, CA 92121